Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

Zymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation

IRVINE, Calif., Nov. 13, 2024 /PRNewswire/ -- Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United District Court for the Central District of California against Qiagen GmbH (Qiagen) alleging that Qiagen has...

2024-11-13 00:54 1158

The Sigourney Award-2024 Recipients Honored For Outstanding Work Advancing Psychoanalytic Principles Globally

Four Recipients' Work From Israel, Sweden, Canada and South Africa Earns The Sigourney Award-2024 SEATTLE, Nov. 12, 2024 /PRNewswire/ -- The Sigourney Award Trust annually recognizes outstanding work that advances psychoanalytic thought and principles throughout the world.Robin A. Deutsch, PhD a...

2024-11-12 22:20 1146

The Sigourney Award-2024 Recipients Honored For Outstanding Work Advancing Psychoanalytic Principles Globally

Hospital Sant Pau and Huawei join forces to accelerate digital transformation in healthcare

BARCELONA, Spain, Nov. 12, 2024 /PRNewswire/ -- Industry Leaders from Hospital de Sant Pau and Huawei today outlined a vision of how digital technology can make hospitals more efficient and improve patients' lives. The speakers shared their though...

2024-11-12 22:04 1137

Hospital Sant Pau and Huawei join forces to accelerate digital transformation in healthcare

Insilico Medicine Announces Positive Topline Results of ISM001-055 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Developed Using Generative AI

Highlights: * ISM001-055 was safe and well-tolerated with a favorable PK profile in IPF patients * Patients who received ISM001-055 showed dose-dependent improvement in the efficacy endpoint, as measured by change in forced vital capacity (FVC) at 12 weeks CAMBRIDGE, Mass., Nov. 12, 2024 /...

2024-11-12 22:00 1024

Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders

Ground-breaking investigation leverages Metabolon's Global Discovery Panel for metabolite genome-wide association study (MGWAS) for cerebrospinal fluid (CSF) and brain metabolite levels as they pertain to neurodegenerative disorders MORRISVILLE, N.C., Nov. 12, 2024 /PRNewswire/ -- Metabolon, Inc....

2024-11-12 22:00 1132

Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing

* Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for the global Antibody-Drug Conjugate (ADC) industry. * Chime Biologics will leverage its CMC expertise in biologics to manage Antibody Intermediate, ADC Drug Substance and Drug P...

2024-11-12 21:15 1325

Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne

-Phase III trial enrolled a total of 480 patients with moderate to severe acne -Topline results expected in the second quarter 2025 HANGZHOU, China, Nov. 12, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III c...

2024-11-12 19:30 1349

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

* After two weeks of treatment, GZR18 tablets resulted in an average weight reduction of up to 4.16%, with continued weight loss observed even after discontinuation. * The pharmacokinetic profile supports a once-daily oral dosing regimen for GZR18 tablets. * The safety and tolerability of G...

2024-11-12 19:00 1157

2024 Tsingke High-Impact Literature Compilation - Gene Synthesis

BEIJING, Nov. 12, 2024 /PRNewswire/ -- Tsingke has delivered high-quality biotechnology services and products to nearly 300,000 users globally. The number of high-level academic papers published using Tsingke's products and services has grown steadily year after year, ...

2024-11-12 18:09 948

deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk

REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower the risk of several diseases. Kari Stefansson and Gudmundur Einarsson, scientists at deCODE genetic...

2024-11-12 18:00 1054

Tsingke Successfully Showcases Innovations at BIO-Europe 2024

BEIJING, Nov. 12, 2024 /PRNewswire/ -- Tsingke proudly concluded its participation in BIO-Europe 2024, held fromNovember 4 to 6 inStockholm, Sweden. As one of the premier global events for the biotechnology, pharmaceutical, and investment sectors, over 5,500 attendees ...

2024-11-12 17:07 924

World's First Patent Acquired for Animal Supplement "Pinfenon" (S) (R)

- Patent Covers Invention of Treatment Drug and Prophylactic Drug for Lowering Cardiac Disorder Markers in Dogs as Well as Their Manufacturing Methods - TOKYO, Nov. 12, 2024 /PRNewswire/ -- Scarecrow Incorporated, based in Tokyo's Shibuya Ward, is pleased to announce that it has acquired the worl...

2024-11-12 14:00 1187

Fosun International Wins "The Asset ESG Corporate Awards 2024 - Platinum Award" and "Best Initiative in Social Responsibility" from The Asset

HONG KONG, Nov. 12, 2024 /PRNewswire/ -- On the evening of 7 November 2024, The Asset, a renowned Asian financial magazine, held "The Asset ESG Corporate Awards 2024" awards ceremony at the Four Seasons Hotel Singapore. Fosun International Limited ("Fosun International" or the "Company") (HKEX st...

2024-11-12 10:35 1379

WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment

SHANGHAI, Nov. 11, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has been ranked #1 in the global Life Sciences Tools & Services sector in the 2024 S&P Glo...

2024-11-12 08:00 1095

PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with Its Microarray Detection Platform

PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection withhigher throughput for efficient and accurate diagnosis. SAN ANTONIO, Nov. 11, 2024 /PRNewswire/ -- Frost & Sullivan recently assessed the multiplexed urinary tract infection detection ind...

2024-11-11 23:00 1195

HoneyNaps AI Diagnostic Medical Software as Featured in International Journal "Digital Health"

- Published clinical study on sleep apnea patients in the prestigious journal Digital Health - Clinical research on HoneyNaps SOMNUM validates its clinical efficacy BOSTON, Nov. 11, 2024 /PRNewswire/ -- Medical AI company HoneyNaps has published a paper demonstrating the clinical value and effic...

2024-11-11 22:00 904

HoneyNaps AI Diagnostic Medical Software as Featured in International Journal

Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.

Acquisition Strengthens Lakeside's Pharmaceutical Logistics Capabilities in China, Projected to Add US$7 Million in Annual Revenue ITASCA, Ill., Nov. 11, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain s...

2024-11-11 21:45 1478

Economist Impact's 4th edition Future of Health Asia to empower healthcare stakeholders by building strategies for a sustainable healthcare system, and igniting investment for an inclusive and healthier future

Members of the media are invited to register here . SINGAPORE, Nov. 11, 2024 /PRNewswire/ -- The 4th edition Future of Health A...

2024-11-11 20:56 1768

Economist Impact's 4th edition Future of Health Asia to empower healthcare stakeholders by building strategies for a sustainable healthcare system, and igniting investment for an inclusive and healthier future

Diabetes Singapore and GSK Join Forces to Spotlight Increased Risk of Viral Infections for People with Diabetes

* Diabetes Singapore and GSK aim to enhance awareness and improve lives affected by diabetes through educational talks and activities on World Diabetes Day * 1 in 3 people will get shingles in their lifetime; People with diabetes are 38% more likely to contract shingles[1] * People with dia...

2024-11-11 20:47 1245

Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe

Highlights: * Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis * Orphan Designation offers 10 years of market exclusivity in Europe upon product approval, along with additional regulat...

2024-11-11 20:30 1006

1 ... 4 5 678 9 10 ... 847